Inventor

Anvarhusein A. Isab

Inventor
Dhahran, SA

Overview

41→
Patents
2014–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 41 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Fprimary
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium34%
A61KPreparations for medical, dental or toiletry purposes31%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
A61NElectrotherapy6%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2%
PatentTitleYear
11,117,912Platinum(II) complexes containing dicyclopentadiene and dithiocarbamate as anticancer agents202110,562,928Pharmaceutical composition containing a cisplatin and platinum thiocyanate combination202010,544,165Method of treating cancer and other proliferative diseases with a gold(I) complex202010,538,544Method for administering cisplatin and a thiocyanate complex to treat ovarian cancer202010,533,029Anticancer trans-diaminoplatinum(II) complexes of selenones202010,507,213Method for treating cancer using a selenourea-coordinated gold(I)-carbene complex201910,494,392Method of treating cancer with a two-component anti-cancer composition201910,494,394Synthesis, x-ray structures and cytotoxic behavior of platinum (II) complexes of dithiocarbamates201910,494,391Two-component anti-cancer composition201910,369,128Pharmaceutical composition containing a cis-diamine platinum thione complex201910,357,473Method for treating a prolifitive disorder with a cis-diamine platinum complex201910,358,456Platinum(II) complexes with selone ligands and method of use201910,336,779Gold(I) complexes, pharmaceutical compositions thereof, and methods of treating cancer201910,301,335Gold complex-containing cancer activity composition201910,294,254DNA/Dithiocarbamato phosphine metal complex201910,278,944Anticancer activity of cis-diamine platinum(II) complexes of thiones201910,280,187Mononucleotide-dithiocarbamate complex201910,273,257Cancer cell-containing composition201910,189,865Gold(I) complexes, pharmaceutical compositions thereof, and methods of treating proliferative disorders201910,172,823Method for inhibiting cancer cell growth with a transplatin complex201910,160,773Method for inducing cytotoxicity in cancer cells201810,144,749Gold complexes of alkylated phosphines201810,093,689Composition containing a gold (I) complex and cancer cells201810,092,579Gold(I) complexes with anticancer properties and methods of use thereof201810,077,280Mixed ligand gold(I) complexes as anti-cancer agents20189,994,592Anticancer activity of gold(III) complexes of meso-1,2-di(1-naphthyl)-1,2-diaminoethane20189,974,765Transplatin derivatives as anticancer agents20189,880,170'Gluthatione/gold(III) pharmaceutical composition'20189,840,528'Thione-platinum(II) complexes and pharmaceutical compositions thereof'20179,796,734'Gold(III) anti-cancer agents'20179,782,380'Method for treating ovarian cancer and/or Hodgkin lymphomia with a gold(III) complex'20179,657,035'Method of treating cancer and gold(III) complexes as anti-cancer agents'20179,649,292'Method for treating prostate cancer and/or gastrointestinal cancer'20179,585,861'Method for treating a cancer with a mixed ligand gold(III) complexes as anti-cancer agents'20179,572,822'Treatment of cervical cancer with gold(I) complexes'20179,573,967'N-heterocyclic carbene gold complexes with anticancer properties and methods of use thereof'20179,492,465'Gold(I) complexes with t-butyl phosphine and dialkyl dithiocarbamate ligands'20169,487,542'Mixed ligand gold(III) complexes and methods thereof'20169,481,699'Platinum(II) complexes with thione ligands and methods thereof'20169,481,693'Mixed ligand gold(III) complexes as anti-cancer agents'20168,895,611'Cytotoxic compounds for treating cancer'2014

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2014–2021Patents assigned to UNIV KING FAHD PET & MINERALS (41)· patent assignee history
2014–2017Patents assigned to KING ABDULAZIZ CITY SCI & TECH (3)· patent assignee history
2014–2021Based in Dhahran, SA· patent location history
2018–2021Patents assigned to UNIV KING SAUD (9)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV KING FAHD PET & MINERALS412014–2021
UNIV KING SAUD92018–2021
KING ABDULAZIZ CITY SCI & TECH32014–2017
Locations
LocationPatentsSpan
Dhahran, SA412014–2021